Reaction

T-Cell Prolymphocytic Leukaemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 92 reports · 3 co-occurring drugs

As of the last recalculation, T-Cell Prolymphocytic Leukaemia appears in 92 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 601.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Alemtuzumab	33	601.4	602.4
Cladribine	7	178.3	178.4
Venetoclax	28	147.4	147.5

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.